These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
192 related items for PubMed ID: 9168800
21. Induction of salivary gland epithelial cell injury in Sjogren's syndrome: in vitro assessment of T cell-derived cytokines and Fas protein expression. Abu-Helu RF, Dimitriou ID, Kapsogeorgou EK, Moutsopoulos HM, Manoussakis MN. J Autoimmun; 2001 Sep; 17(2):141-53. PubMed ID: 11591123 [Abstract] [Full Text] [Related]
22. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes. Gastman BR, Atarshi Y, Reichert TE, Saito T, Balkir L, Rabinowich H, Whiteside TL. Cancer Res; 1999 Oct 15; 59(20):5356-64. PubMed ID: 10537320 [Abstract] [Full Text] [Related]
23. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand. Mitsiades N, Poulaki V, Tseleni-Balafouta S, Koutras DA, Stamenkovic I. Cancer Res; 2000 Aug 01; 60(15):4122-9. PubMed ID: 10945619 [Abstract] [Full Text] [Related]
24. Fas/Fas ligand interaction regulates cytotoxicity of CD4+ T cells against staphylococcal enterotoxin B-pulsed endothelial cells. Urayama S, Kawakami A, Matsuoka N, Tsuboi M, Nakashima T, Kawabe Y, Koji T, Eguchi K. Biochem Biophys Res Commun; 1997 Oct 29; 239(3):782-8. PubMed ID: 9367846 [Abstract] [Full Text] [Related]
25. Mechanisms of neutrophil apoptosis in uremia and relevance of the Fas (APO-1, CD95)/Fas ligand system. Jaber BL, Perianayagam MC, Balakrishnan VS, King AJ, Pereira BJ. J Leukoc Biol; 2001 Jun 29; 69(6):1006-12. PubMed ID: 11404388 [Abstract] [Full Text] [Related]
26. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production. Shustov A, Nguyen P, Finkelman F, Elkon KB, Via CS. J Immunol; 1998 Sep 15; 161(6):2848-55. PubMed ID: 9743345 [Abstract] [Full Text] [Related]
27. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. Ungefroren H, Voss M, Jansen M, Roeder C, Henne-Bruns D, Kremer B, Kalthoff H. Cancer Res; 1998 Apr 15; 58(8):1741-9. PubMed ID: 9563493 [Abstract] [Full Text] [Related]
28. Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells. Villunger A, Egle A, Kos M, Hartmann BL, Geley S, Kofler R, Greil R. Cancer Res; 1997 Aug 15; 57(16):3331-4. PubMed ID: 9269989 [Abstract] [Full Text] [Related]
29. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway. Ashany D, Savir A, Bhardwaj N, Elkon KB. J Immunol; 1999 Nov 15; 163(10):5303-11. PubMed ID: 10553053 [Abstract] [Full Text] [Related]
30. Hepatitis B virus X protein sensitizes UV-induced apoptosis by transcriptional transactivation of Fas ligand gene expression. Kim SY, Kim JK, Kim HJ, Ahn JK. IUBMB Life; 2005 Sep 15; 57(9):651-8. PubMed ID: 16203685 [Abstract] [Full Text] [Related]
31. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively. Hashimoto W, Osaki T, Okamura H, Robbins PD, Kurimoto M, Nagata S, Lotze MT, Tahara H. J Immunol; 1999 Jul 15; 163(2):583-9. PubMed ID: 10395644 [Abstract] [Full Text] [Related]
32. Fas mediates apoptosis and oxidant-induced cell death in cultured hRPE cells. Jiang S, Wu MW, Sternberg P, Jones DP. Invest Ophthalmol Vis Sci; 2000 Mar 15; 41(3):645-55. PubMed ID: 10711676 [Abstract] [Full Text] [Related]
33. Ultraviolet light-induced immune tolerance is mediated via the Fas/Fas-ligand system. Schwarz A, Grabbe S, Grosse-Heitmeyer K, Roters B, Riemann H, Luger TA, Trinchieri G, Schwarz T. J Immunol; 1998 May 01; 160(9):4262-70. PubMed ID: 9574528 [Abstract] [Full Text] [Related]
34. Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruption. Choi HJ, Ku JK, Kim MY, Kang H, Cho SH, Kim HO, Park YM. Br J Dermatol; 2006 Mar 01; 154(3):419-25. PubMed ID: 16445769 [Abstract] [Full Text] [Related]
35. Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human gamma delta T cells: a mechanism for the loss of gamma delta T cells in patients with pulmonary tuberculosis. Li B, Bassiri H, Rossman MD, Kramer P, Eyuboglu AF, Torres M, Sada E, Imir T, Carding SR. J Immunol; 1998 Aug 01; 161(3):1558-67. PubMed ID: 9686624 [Abstract] [Full Text] [Related]
36. Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing. Rivoltini L, Radrizzani M, Accornero P, Squarcina P, Chiodoni C, Mazzocchi A, Castelli C, Tarsini P, Viggiano V, Belli F, Colombo MP, Parmiani G. J Immunol; 1998 Aug 01; 161(3):1220-30. PubMed ID: 9686582 [Abstract] [Full Text] [Related]
37. Suppression of human B cell responsiveness by CD4+ T cells does not involve CD95-CD95 ligand interactions. Hirohata S. Cell Immunol; 1997 Nov 01; 181(2):182-91. PubMed ID: 9398405 [Abstract] [Full Text] [Related]
38. [FasL-Fas/APO-1 (CD95) system]. Sun CK, Ju G. Sheng Li Ke Xue Jin Zhan; 1997 Apr 01; 28(2):136-8. PubMed ID: 11038707 [No Abstract] [Full Text] [Related]
40. Fas and Fas ligand interaction is necessary for human osteoblast apoptosis. Kawakami A, Eguchi K, Matsuoka N, Tsuboi M, Koji T, Urayama S, Fujiyama K, Kiriyama T, Nakashima T, Nakane PK, Nagataki S. J Bone Miner Res; 1997 Oct 01; 12(10):1637-46. PubMed ID: 9333124 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]